MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2019 International Congress

    Comparison of motor and non-motor symptoms in operated and medically treated dystonia patients

    A. Maurer, U. Hidding, W. Hamel, C. Moll, C. Gerloff, M. Gelderblom, S. Zittel-Dirks (Hamburg, Germany)

    Objective: To evaluate motor and psychiatric symptoms as well as quality of life (QoL) in dystonia patients treated with botulinumtoxin/medication (non-DBS group) and deep brain…
  • 2019 International Congress

    Genetic and clinical investigation of young onset dystonia in Korea: What can we learn?

    JW. Cho, M. Kim, JK. Park, J. Ahn, J. Youn (Seoul, Republic of Korea)

    Objective: In this study, we performed whole exome sequencing (WES) in Korean patients with young-onset dystonia, and investigated important factors associated with WES in dystonia.…
  • 2019 International Congress

    Defining biomarkers to discriminate between organic and functional dystonia

    A. Stephan, D. Benninger (Lausanne, Switzerland)

    Objective: Establish methodologies, fast and easy to translate to clinics, that help discriminate between organic and functional dystonia. Background: Functional dystonias are challenging diagnoses that…
  • 2019 International Congress

    Biallelic ZNF142-null mutations in patients with early-onset generalized dystonia

    M. Zech, M. Skorvanek, V. Han, P. Dosekova, Z. Gdovinova, M. Wagner, R. Berutti, T. Strom, P. Havránková, A. Fečíková, F. Laccone, R. Jech, J. Winkelmann (Munich, Germany)

    Objective: To identify a novel genetic factor contributing to the phenotypic expression of early-onset generalized dystonia. Background: To date, only about 20-30% of cases with…
  • 2019 International Congress

    Natural History of Movement Abnormalities on Hereditary Spastic Paraplegia: validation of timed functional instruments

    J. Saute, G. Machado, AP. Zanardi, V. Martins, D. Burguêz, L. Jacinto-Scudeiro, E. Monteiro, L. Peyré-Tartaruga (Porto Alegre, Brazil)

    Objective: To evaluate the natural history of Hereditary Spastic Paraplegia (HSPs) and to define sensitivity to change, minimal clinically important difference (MCID) and validity of…
  • 2019 International Congress

    The Impact of the New Classification Criteria on the Incidence of Tremor Syndromes

    A. Avila, N. Caballol, A. Planas-Ballvé, MI. Gómez-Ruiz, M. Balagué-Marmaña, X. Cardona (Barcelona, Spain)

    Objective: To compare the incidence of the different tremor syndromes using 1998 versus 2018 consensus criteria for classifying tremor disorders. Background: In 1998, the Consensus…
  • 2019 International Congress

    Prevalence and Patterns of Rest and Action Tremor in Drug-naïve Parkinson’s Disease

    D. Gupta, J. Boyd, S. Kuo (Burlington, VT, USA)

    Objective: We aimed to describe the prevalence and patterns of rest and action tremor in a large, prospective cohort of Parkinson’s disease (PD) patients. Background:…
  • 2019 International Congress

    GluRδ2 protein reduction in cerebellar Purkinje cells contributes to the pathogenesis of essential tremor

    MK. Pan, YS. Li, CL. Ni, WC. Liu, E. Cortes, JP. Vonsattel, E. Louis, P. Faust, SH. Kuo (Taipei, Taiwan)

    Objective: To identify a molecular substrate reflecting kinetic tremor, the core feature of essential tremor (ET) Background: ET is one of the most common movement…
  • 2019 International Congress

    Dystonic versus parkinsonian tremor

    J. Svantnerova, Z. Kosutzka, M. Minar (Bratislava, Slovakia)

    Objective: To present cases of patients with diagnostic uncertainty between tremor in Parkinson’s disease (PD) and dystonic tremor. Background: Some patients with clinical presentation of…
  • 2019 International Congress

    Memantine induced dyskinesia in Alzheimer’s disease

    M. Kaiserova, L. Hvizdošova, K. Mensikova, P. Kanovsky (Olomouc, Czech Republic)

    Objective: There is only little evidence for memantine induced dyskinesia in Alzheimer’s disease. We present a patient with Alzheimer’s disease who developed choreatic dyskinesia as a result…
  • « Previous Page
  • 1
  • …
  • 197
  • 198
  • 199
  • 200
  • 201
  • …
  • 217
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
    • DaTscan in clinical evaluation of Multiple System Atrophy
    • Effect of marijuana on Essential Tremor: A case report
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
    • Patients with Essential Tremor Live Longer than their Relatives
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley